Is a complete RLMD research report available?

No complete published report is available for Relmada Therapeutics, Inc. (RLMD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Relmada Therapeutics, Inc. (RLMD)

NASDAQ: RLMD · USD

$3.34

+0.13 (+4.0%)· Recorded snapshot

Market cap	356.3M
Net income (ttm)	-61.9M
EPS (ttm)	-$0.85
Shares out	106.7M
Volume	1,477,510
Beta	0.51

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -61.9M
EPS (ttm): -$0.85
Market cap: 356.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Metric	Value
Amount currency	USD
CIK code	0001553643
Company name	Relmada Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	75955J402
Earnings date	2026-11-12
Earnings time	amc
Employees	17
Employees change	-3
Employees growth	-15%
Enterprise value	$138.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2004
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US75955J4022
Last 10-K release date	2026-03-19
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2019-09-30
Last stock split type	Reverse
Market cap	$356.3M
Market cap category	Small-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$3.34
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	RLMD
U.S. state	Florida
Website	https://www.relmada.com

Metric

Value

Amount currency

USD

CIK code

0001553643

Company name

Relmada Therapeutics, Inc.

Country

United States

Country code

CUSIP number

75955J402

Earnings date

2026-11-12

Earnings time

amc

Employees

Employees change

-3

Employees growth

-15%

Enterprise value

$138.5M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2004

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US75955J4022

Last 10-K release date

2026-03-19

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2019-09-30

Last stock split type

Reverse

Market cap

$356.3M

Market cap category

Small-Cap

Next earnings date

2026-11-12

Options

Yes

Price

$3.34

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

RLMD

U.S. state

Florida

Website

https://www.relmada.com

Metric	Value
Earnings yield	-25.31%
FCF / EV yield	-34.94%
FCF yield	-13.17%
P/B ratio	1.66x
Price / tangible book value	1.69x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-25.31%

FCF / EV yield

-34.94%

FCF yield

-13.17%

P/B ratio

1.66x

Price / tangible book value

1.69x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-3.6M
ROA	-32.39%
ROA (5Y)	-54.95%
ROCE	-29.41%
ROE	-55.66%
ROE (5Y)	-96.82%
ROIC	-34.96%

Metric

Value

Profit per employee

$-3.6M

ROA

-32.39%

ROA (5Y)

-54.95%

ROCE

-29.41%

ROE

-55.66%

ROE (5Y)

-96.82%

ROIC

-34.96%

Metric	Value
EPS growth quarters	17
EPS growth years	4
Net income growth years	3
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
EBIT	$-62.2M
EPS	$-0.85
FCF per share	$-0.43
Financing cash flow	$243.8M
Free cash flow	$-46M
Free cash flow minus SBC	$-60.7M
Investing cash flow	$-187.8M
Net cash flow	$10M
Net income	$-61.9M
Operating cash flow minus SBC	$-60.7M
Operating income	$-62.2M
Stock-based compensation	$14.7M

Metric

Value

EBIT

$-62.2M

EPS

$-0.85

FCF per share

$-0.43

Financing cash flow

$243.8M

Free cash flow

$-46M

Free cash flow minus SBC

$-60.7M

Investing cash flow

$-187.8M

Net cash flow

$10M

Net income

$-61.9M

Operating cash flow minus SBC

$-60.7M

Operating income

$-62.2M

Stock-based compensation

$14.7M

Metric	Value
Book value per share	$1.94
Debt / equity	0
Long-term assets	$19,500
Long-term liabilities	$5.1M
Net cash (debt)	$217.7M
Net cash / market cap	62.33%
Net cash growth	955.95%
Net debt / equity	-1.05
Piotroski F-Score	2
Shareholders' equity	$206.6M
Tangible book value	$206.6M
Tangible book value per share	$1.94
Total assets	$219.1M
Total cash	$217.7M
Total debt	$0
Total liabilities	$12.5M
WACC	7.07%

Metric

Value

Book value per share

$1.94

Debt / equity

Long-term assets

$19,500

Long-term liabilities

$5.1M

Net cash (debt)

$217.7M

Net cash / market cap

62.33%

Net cash growth

955.95%

Net debt / equity

-1.05

Piotroski F-Score

Shareholders' equity

$206.6M

Tangible book value

$206.6M

Tangible book value per share

$1.94

Total assets

$219.1M

Total cash

$217.7M

Total debt

Total liabilities

$12.5M

WACC

7.07%

Metric	Value
Current assets	$219M
Current liabilities	$7.4M
Current ratio	29.52
Net working capital	$-6.1M
Quick ratio	29.34
Working capital	$211.6M

Metric

Value

Current assets

$219M

Current liabilities

$7.4M

Current ratio

29.52

Net working capital

$-6.1M

Quick ratio

29.34

Working capital

$211.6M

Metric	Value
Buyback yield / dilution	-136.32%
Dividend yield	0%
Shareholder yield	-136.32%

Metric

Value

Buyback yield / dilution

-136.32%

Dividend yield

Shareholder yield

-136.32%

Metric	Value
10Y price change	-28.4%
10Y return CAGR	-3.29%
10Y total return	-28.4%
150-day SMA	$5.60
1D price change	4.05%
1M price change	-14.75%
1M total return	-14.75%
1W price change	-2.83%
1W total return	-2.83%
1Y price change	40.13%
1Y return CAGR	40.16%
1Y total return	40.13%
20-day SMA	$3.31
200-day SMA	$5.36
3M price change	-37.21%
3M total return	-37.21%
3Y price change	9.2%
3Y return CAGR	2.98%
3Y total return	9.2%
50-day SMA	$3.89
50-day SMA vs 200-day SMA	50under200
52-week high	$8.00
52-week high date	2026-05-06
52-week low	$2.15
52-week low date	2025-11-03
5Y price change	-85.8%
5Y return CAGR	-32.33%
5Y total return	-85.8%
6M price change	-53.56%
6M total return	-53.56%
All-time high	$80.00
All-time high date	2014-10-29
All-time low	$0.24
All-time low date	2025-03-03
Average true range (ATR)	$0.20
Average volume	1.6M
Beta (1Y)	0.25
Beta (2Y)	1.25
Beta (5Y)	0.51
Change from 52-week high	-58.25%
Change from 52-week low	55.35%
Change from all-time high	-95.92%
Change from all-time low	1,258.15%
Change from open	4.05%
Day's gap	0%
Dollar volume	$4.9M
High price	$3.35
Low price	$3.19
Monthly RSI	44.89
Open price	$3.21
Position in 52-week range	93.75%
Premarket change	0.62%
Premarket close	$3.21
Premarket price	$3.23
Previous close	$3.21
Price vs 150-day SMA	-41.68%
Price vs 20-day SMA	-1.42%
Price vs 200-day SMA	-39.1%
Price vs 50-day SMA	-16.09%
Relative volume	0.94
RSI	40.32
Sharpe ratio	0.73
Sharpe ratio (3Y)	0.69
Sharpe ratio (5Y)	0.34
Sortino ratio	1.6
Sortino ratio (3Y)	1.14
Sortino ratio (5Y)	0.55
Volume	1.5M
Weekly RSI	32.61
YTD price change	-32.4%
YTD total return	-32.4%

Metric

Value

10Y price change

-28.4%

10Y return CAGR

-3.29%

10Y total return

-28.4%

150-day SMA

$5.60

1D price change

4.05%

1M price change

-14.75%

1M total return

-14.75%

1W price change

-2.83%

1W total return

-2.83%

1Y price change

40.13%

1Y return CAGR

40.16%

1Y total return

40.13%

20-day SMA

$3.31

200-day SMA

$5.36

3M price change

-37.21%

3M total return

-37.21%

3Y price change

9.2%

3Y return CAGR

2.98%

3Y total return

9.2%

50-day SMA

$3.89

50-day SMA vs 200-day SMA

50under200

52-week high

$8.00

52-week high date

2026-05-06

52-week low

$2.15

52-week low date

2025-11-03

5Y price change

-85.8%

5Y return CAGR

-32.33%

5Y total return

-85.8%

6M price change

-53.56%

6M total return

-53.56%

All-time high

$80.00

All-time high date

2014-10-29

All-time low

$0.24

All-time low date

2025-03-03

Average true range (ATR)

$0.20

Average volume

1.6M

Beta (1Y)

0.25

Beta (2Y)

1.25

Beta (5Y)

0.51

Change from 52-week high

-58.25%

Change from 52-week low

55.35%

Change from all-time high

-95.92%

Change from all-time low

1,258.15%

Change from open

4.05%

Day's gap

Dollar volume

$4.9M

High price

$3.35

Low price

$3.19

Monthly RSI

44.89

Open price

$3.21

Position in 52-week range

93.75%

Premarket change

0.62%

Premarket close

$3.21

Premarket price

$3.23

Previous close

$3.21

Price vs 150-day SMA

-41.68%

Price vs 20-day SMA

-1.42%

Price vs 200-day SMA

-39.1%

Price vs 50-day SMA

-16.09%

Relative volume

0.94

RSI

40.32

Sharpe ratio

0.73

Sharpe ratio (3Y)

0.69

Sharpe ratio (5Y)

0.34

Sortino ratio

1.6

Sortino ratio (3Y)

1.14

Sortino ratio (5Y)

0.55

Volume

1.5M

Weekly RSI

32.61

YTD price change

-32.4%

YTD total return

-32.4%

Metric	Value
Float	82.6M
Float percentage	77.47%
Shares change (QoQ)	29.77%
Shares change (YoY)	136.32%
Shares held by insiders	3.23%
Shares held by institutions	75.04%
Shares outstanding	106.7M
Short % of float	14.74%
Short % of shares	11.42%
Short ratio	10.6 days

Metric

Value

Float

82.6M

Float percentage

77.47%

Shares change (QoQ)

29.77%

Shares change (YoY)

136.32%

Shares held by insiders

3.23%

Shares held by institutions

75.04%

Shares outstanding

106.7M

Short % of float

14.74%

Short % of shares

11.42%

Short ratio

10.6 days

Relmada Therapeutics, Inc. (RLMD)

Price

Financial snapshot

Fair-value bridge

Latest news · RLMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RLMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on RLMD

Frequently asked questions